🇺🇸 FDA
Patent

US 11744898

Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

granted A61KA61K47/54A61K47/60

Quick answer

US patent 11744898 (Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods) held by Nektar Therapeutics expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/54, A61K47/60, A61K47/642, A61K9/0029